首页> 外文期刊>Amyotrophic lateral sclerosis eofficial publication of the World Federation of Neurology Research Group on Motor Neuron Diseases >SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management
【24h】

SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management

机译:加拿大不列颠哥伦比亚省的ALS患者中SOD1基因突变:临床特征,神经生理学和管理中的道德问题

获取原文
获取原文并翻译 | 示例
           

摘要

Two hundred and fifty-four ALS patients from British Columbia, Canada were screened for mutations in the gene encoding the enzyme superoxide dismutase type 1 (SOD1). Thirteen patients (5.1%) carried one of six missense mutations (A4V, G72C, D76Y, D90A, C111Y, I113T). Mutations were found both in sporadic and familial ALS cases. Atypical clinical features delayed diagnosis in some cases. The demographic and clinical features of the mutation carrying index cases are summarized, and compared with those of screened patients without mutations. The phenotypic variability between SOD1 mutation carrying patients in this study is dramatic, even among patients with the same mutation This underlines the hypothesis that ALS is a biologically heterogeneous disorder in which genetics, environment and ageing all interrelate to form the final clinical phenotype.
机译:筛选了来自加拿大不列颠哥伦比亚省的254例ALS患者的编码超氧化物歧化酶1型(SOD1)的基因中的突变。 13名患者(5.1%)携带了6个错义突变之一(A4V,G72C,D76Y,D90A,C111Y,I113T)。在散发性和家族性ALS病例中均发现了突变。非典型临床特征在某些情况下延误了诊断。总结了携带突变的病例的人口统计学和临床​​特征,并与经筛选的无突变的患者进行了比较。即使在具有相同突变的患者中,该研究中携带SOD1突变的患者之间的表型变异也是巨大的。这突显了以下假设:ALS是一种生物学上异质的疾病,其中遗传,环境和衰老都相互关联以形成最终的临床表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号